MMV Medicines For Malaria Venture

Meyrin, GE

UEI
NMUQLS4KJ9V4
CAGE
SDZ55
Primary NAICS
325411 Medicinal and Botanical Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Non-Profit Organization
  • Foundation
Entity structure
Corporate Entity (Tax Exempt)
SAM.gov registration date
Physical address
International University in Geneva, Rte de Pré-Bois 20, 1215 Meyrin, Switzerland
Website
mmv.org
Founded
1999
Employees
51-250
Estimated annual revenue
$10M-$50M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Grant subawards

Prime recipient Prime award Amount Awarded
Regents Of The University Of Minnesota Preclinical Development of MMV609, a Second-Generation ATP4i, for Malaria HT94252510648 $801,700

Quick answers

Is MMV Medicines For Malaria Venture registered in SAM.gov?

Yes. MMV Medicines For Malaria Venture's SAM.gov registration is active through January 28, 2027.

What is MMV Medicines For Malaria Venture's most recent federal award?

MMV Medicines For Malaria Venture's most recent federal grant award is Medicines for malaria (7200AA23FA00010), from Bureau for Global Health (USAID), on October 1, 2023.

On GovTribe

See MMV Medicines For Malaria Venture's full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors